Latest News and Press Releases
Want to stay updated on the latest news?
-
H1 2022/23 Regnskabsmeddelelse, 1. halvår 2022/23 1. oktober 2022 – 31. marts 2023 Coloplast leverede en organisk vækst på 8% og en overskudsgrad på 28% i andet kvartal1). Den...
-
H1 2022/23 Interim financial results, H1 2022/23 1 October 2022 - 31 March 2023 Coloplast delivered Q2 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK was up by 10%. ...
-
A new multi-center, prospective, two-phase clinical trial1 supported by Atos Medical, a leading company in laryngectomy care, demonstrates a significant improvement in cough and sputum symptoms,...
-
Studieresultater viser, at Coloplasts nye engangskateter med mere end 80 mikrohuller, Luja, opnåede fuldstændig blæretømning i frit flow* i 90% af kateteriseringerne, mens Hollister’s VaPro™ med to...
-
Study results show that Coloplast’s new intermittent male catheter with 80+ micro-holes, Luja, achieved complete bladder emptying in one free flow* in 90% of catheterisations, while Hollister’s...
-
Se venligst vedlagte pdf. Vedhæftet fil 01032023_handel_med_aktier_GL ...
-
Please see enclosed pdf. Attachment 01032023_trading_in_shares_GL ...
-
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer I henhold til Markedsmisbrugsforordningen art. 19 skal Coloplast indberette...
-
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is...
-
The new intermittent catheter Luja™ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a...